Autobacs Seven Co (9832) AI Stock Analysis

• Market Cap: ¥120.02B
• Dividend Yield: 3.9%
• Average Volume (3M): 160.31K
• Price to Earnings (P/E): 12.9
• Beta (1Y): 0.40
• Revenue Growth: 14.83%
• EPS Growth: 62.73%
• Country: JP
• Employees: 4,385
• Sector: Consumer Cyclical
• Sector Strength: 71
• Industry: Specialty Retail
• EPS (TTM): 25.49
• Shares Outstanding: 82,050,100
• 10 Day Avg. Volume: 238,470
• 30 Day Avg. Volume: 160,306
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,645.79
• Price Target Upside: 6.87% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 76 Outperform
• Price Target: ¥1,645.00 ▲(6.82% Upside)

The overall stock score reflects solid financial performance and a fair valuation. The stock benefits from strong revenue growth and a healthy balance sheet, but faces challenges with cash flow management. Technical analysis shows a moderate momentum. The attractive dividend yield enhances the stock's investment appeal.

Autobacs Seven Co Business Overview & Revenue Model

Company Description

Autobacs Seven Co., Ltd. is a Japanese company specializing in the automotive aftermarket sector. Founded in 1947, it operates a network of retail stores offering a wide range of automotive parts, accessories, and services. The company is known for its Autobacs stores, which provide car maintenance and repair services, as well as sales of tires, car electronics, and other automobile-related products. Autobacs Seven Co. is headquartered in Tokyo, Japan, and has expanded its operations internationally, including in Asia and Europe.

How the Company Makes Money

Autobacs Seven Co. generates revenue primarily through its retail operations, selling automotive parts and accessories directly to consumers via its network of Autobacs stores. Additional revenue streams include providing car maintenance and repair services, which attract a steady customer base seeking routine vehicle upkeep and emergency repairs. The company also benefits from its private label products, which offer higher margins compared to third-party brands. Furthermore, Autobacs Seven Co. has established franchise agreements, allowing it to earn franchise fees and royalties from partner-operated stores. The company's international expansion contributes to its revenue by tapping into new markets. Key partnerships with automotive manufacturers and suppliers help secure a diverse product lineup, enhancing customer retention and attracting new clientele.

Autobacs Seven Co Financial Statement Overview

Summary

Autobacs Seven Co exhibits solid revenue and profit growth, with strong margins and a healthy balance sheet. However, the significant decline in cash flow raises concerns about liquidity and operational cash management, which slightly offsets the positive financial indicators.

Income Statement

Autobacs Seven Co has demonstrated strong revenue growth, with a Revenue Growth Rate of 8.55% from 2024 to 2025. The Gross Profit Margin improved to 35.42%, and the Net Profit Margin increased to 3.26% in 2025, reflecting enhanced profitability. However, the EBIT Margin at 4.86% and EBITDA Margin at 7.67% suggest room for operational efficiency improvements.

Balance Sheet

The company maintains a stable financial position with a Debt-to-Equity Ratio of 0.29, indicating conservative leverage. The Return on Equity is healthy at 6.17%, showing effective use of shareholder funds. The Equity Ratio of 57.76% affirms a strong equity base, but there is a slight increase in total debt, which may require monitoring.

Cash Flow

Cash flow from operations decreased significantly, impacting the company's liquidity position. The Operating Cash Flow to Net Income Ratio dropped to 0.48, and Free Cash Flow turned negative at -4982 million, indicating potential cash constraints. The Free Cash Flow to Net Income Ratio is also negative, which is a concern for future investments.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	249.53B	229.86B	236.24B	228.59B	220.45B
Gross Profit	88.37B	75.42B	79.46B	77.15B	73.29B
EBITDA	19.14B	15.66B	16.41B	16.11B	14.73B
Net Income	8.13B	6.36B	7.24B	7.01B	7.05B
Balance Sheet
Total Assets	228.17B	194.95B	194.33B	189.91B	187.91B
Cash, Cash Equivalents and Short-Term Investments	31.29B	31.30B	28.21B	29.07B	43.85B
Total Debt	37.82B	9.32B	12.19B	10.76B	12.66B
Total Liabilities	96.20B	65.80B	67.37B	67.02B	64.08B
Stockholders Equity	131.81B	128.84B	126.62B	122.55B	123.18B
Cash Flow
Free Cash Flow	-4.98B	5.28B	3.50B	-588.00M	13.17B
Operating Cash Flow	3.94B	14.43B	10.69B	5.71B	17.16B
Investing Cash Flow	-18.02B	-449.00M	-7.65B	-7.71B	-6.08B
Financing Cash Flow	13.97B	-7.41B	-3.50B	-12.30B	-309.00M

Autobacs Seven Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1540.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9832, the sentiment is Positive. The current price of 1540 is above the 20-day moving average (MA) of 1475.55, above the 50-day MA of 1456.66, and above the 200-day MA of 1442.65, indicating a bullish trend. The MACD of 20.01 indicates Negative momentum. The RSI at 83.47 is Negative, neither overbought nor oversold. The STOCH value of 95.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9832.

Autobacs Seven Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2674	81 Outperform	¥24.21B	11.06		4.36%	8.63%	-3.75%
9832	76 Outperform	¥120.02B	12.85	7.64%	3.90%	14.83%	62.73%
2666	71 Outperform	¥2.24B	7.63		1.94%	9.21%	24.86%
2751	70 Outperform	¥40.48B	19.82		0.26%	26.92%	4.19%
2730	68 Neutral	¥210.58B	14.14		2.33%	5.78%	40.57%
2681	61 Neutral	¥65.72B	19.16		2.06%	1.10%	-64.41%
Sector *	61 Neutral	C$4.66B	8.45	13.40%	3.62%	3.19%	-2.46%

Autobacs Seven Co Corporate Events

Autobacs Seven Co. Reports Strong Q1 Financial Growth

Autobacs Seven Co., Ltd. reported significant growth in its financial performance for the three months ended June 30, 2025, with net sales increasing by 18.9% year-on-year to ¥64,223 million. The company also saw substantial rises in operating profit and profit attributable to owners of the parent, indicating a strong recovery from the previous year’s downturn. This positive financial outcome suggests an improved market position and potential benefits for stakeholders, as the company maintains its dividend forecast for the fiscal year ending March 2026.

Autobacs Seven Co. Reports Strong Q1 Financial Performance

Autobacs Seven Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 18.9% year-on-year to ¥64,223 million. The company’s operating profit surged by 154.1%, and profit attributable to owners of the parent increased by 173.9%, reflecting a strong recovery from the previous year’s downturn. This robust performance underscores Autobacs’ improved market positioning and operational efficiency, potentially benefiting stakeholders through enhanced profitability and stability.

Autobacs Seven Completes Disposal of Treasury Shares

Autobacs Seven Co., Ltd. has completed the payment procedures for the disposal of 42,500 treasury shares as restricted stock remuneration, following a resolution made at the Board of Directors’ meeting on June 30, 2025. This move is part of the company’s strategy to allocate shares to its directors, excluding outside directors and those on the audit and supervisory committee, potentially impacting its operational dynamics and shareholder structure.

Autobacs Seven Co. Announces Disposal of Treasury Shares for Director Remuneration

Autobacs Seven Co., Ltd. announced the disposal of 42,500 treasury shares as part of its Restricted Stock Remuneration Plan, aimed at enhancing value sharing with shareholders. This move is intended to motivate directors by aligning their interests with the company’s long-term value, as shares will be held until retirement, fostering sustained corporate value enhancement.

Autobacs Seven Co. Reports Strong Financial Performance for FY2025

Autobacs Seven Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 8.6% and operating profit rising by 51.4% compared to the previous year. The company’s strategic initiatives have resulted in a robust financial position, with a notable increase in profit attributable to owners of the parent by 28%. This financial growth reflects positively on Autobacs’ market positioning and indicates a strong outlook for stakeholders.

Autobacs Seven Co. Reports Strong Financial Growth in FY2025

Autobacs Seven Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with an 8.6% increase in net sales and a 51.4% rise in operating profit compared to the previous year. The company has also forecasted continued growth for the next fiscal year, indicating a strong market position and potential positive impact for stakeholders.